NHF’s QMS is ISO 9001:2015 Certified

Government of Jamaica

Major Depression Gets New Active Ingredient on NHF Drug List

Major Depression Gets New Active Ingredient on NHF Drug List.

National Health Fund (NHF) has added a new active pharmaceutical ingredient – Desvenlafaxine to the NHF Drug List.

This drug under the label Pristiq, is for the treatment of Major Depression and NHF now offers a subsidy of $80.93 for each 50 milligram extended release tablet.

There are approximately nineteen thousand persons enrolled for Major Depression on the NHF Individual Benefits Programme, at the end of May.

Details of the list of NHF subsidies are available from NHF Participating Pharmacies, the NHF website or by calling NHF.

For further information contact Rosemarie Lee, Tel. 906-1106 or Shermaine Robotham, Tel. 322- 0809

National Health Fund © 2024. All Rights Reserved.